IL17A and steatosis: Our study aims to investigate these issues by exploring the connections between IL-17A/F, TLR4, and inflammatory markers, as well as their associations with the severity of steatosis and the likelihood of fibrosis, to identify new biomarkers that could guide future therapeutic strategies.